Page last updated: 2024-09-05

etravirine and rifampin

etravirine has been researched along with rifampin in 2 studies

Compound Research Comparison

Studies
(etravirine)
Trials
(etravirine)
Recent Studies (post-2010)
(etravirine)
Studies
(rifampin)
Trials
(rifampin)
Recent Studies (post-2010) (rifampin)
5729032120,4681,4996,552

Protein Interaction Comparison

ProteinTaxonomyetravirine (IC50)rifampin (IC50)
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.949
Caspase-1Homo sapiens (human)8.319
Alpha-synucleinHomo sapiens (human)7.1
Enoyl-[acyl-carrier-protein] reductase [NADH]Mycobacterium tuberculosis H37Rv0.03
DNA-directed RNA polymerase subunit betaMycobacterium tuberculosis H37Rv0.01
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)1.5
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.5

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cauda, R; Colafigli, M; De Luca, A; Di Giambenedetto, S; Fabbiani, M; Fortuna, S; Gagliardini, R; Navarra, P; Trecarichi, EM; Visconti, E1

Reviews

1 review(s) available for etravirine and rifampin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for etravirine and rifampin

ArticleYear
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis.
    Infection, 2014, Volume: 42, Issue:4

    Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Drug Interactions; Female; HIV Infections; Humans; Nitriles; Plasma; Pyridazines; Pyrimidines; Rifampin; Tuberculosis

2014